REGENXBIO Inc.
RGNX
$9.01
$0.9011.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -76.00% | 319.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -76.00% | 319.59% | |||
| Cost of Revenue | -90.78% | 137.23% | |||
| Gross Profit | -50.29% | -81.22% | |||
| SG&A Expenses | -2.28% | 35.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 200.00% | -98.20% | |||
| Total Operating Expenses | 10.08% | 5.93% | |||
| Operating Income | -621.79% | 123.61% | |||
| Income Before Tax | -1,265.07% | 111.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,265.07% | 111.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,265.07% | 111.88% | |||
| EBIT | -621.79% | 123.61% | |||
| EBITDA | -469.19% | 133.97% | |||
| EPS Basic | -1,262.67% | 111.77% | |||
| Normalized Basic EPS | -1,262.70% | 111.77% | |||
| EPS Diluted | -1,262.67% | 111.77% | |||
| Normalized Diluted EPS | -1,264.28% | 111.75% | |||
| Average Basic Shares Outstanding | 0.24% | 0.97% | |||
| Average Diluted Shares Outstanding | 0.10% | 1.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||